Experience > Prevention

CRAB's Expertise in Cancer Prevention and Control Studies

Prevention research is critical to a comprehensive cancer control plan. By 2030, due to population growth and demographics, the global burden of cancer is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths annually*

Cancer prevention and control clinical trials are diverse, multidisciplinary and designed to inform prevention practices to lower the incidence of cancer, reduce health disparities, improve quality of life and identify cancer and risk biomarkers.

CRAB's expertise in cancer prevention and control research include:

• Design, coordination, data collection and analysis of prevention and control studies
• Access to a network of seasoned investigators
• A network of clinical trials specialists with recruitment experience in special populations
• Multiple strategies for maintaining excellent patient adherence and retention
• Experience in the organization and conduction of training workshops for investigators and staff
• Access to a vast biorepository of specimens and clinical data for translational medicine studies
• Staff with a variety of experience in conducting prevention and control research studies

Examples of CRAB prevention and control research:

• The Selenium and Vitamin E Cancer Prevention Trial (SELECT), which accrued 35,000 men to evaluate if supplements alone or in combination would prevent prostate cancer
  • Experience with direct contact of over 17,700 participants in centralized follow-up by mail, phone and secure web access after the primary trial completed
• An international trial in six Latin American countries to test three different antibiotic regimens to eradicate H. pylori, the principal cause of stomach cancer, accrued over 1,800 subjects.
  • Proven ability to launch and complete trials in rarely studies diseases and locations
  • Demonstrated commitment to developing solutions to worldwide health problems

CRAB is poised to assist clinical investigators with development and implementation of cancer prevention and control studies and to share strategies for recruitment, adherence and long-term follow-up.

*Estimates from the International Agency for Research on Cancer (IARC)